Your browser doesn't support javascript.
loading
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome.
Ni, Mingke; Dadon, Ziv; Ormerod, Julian O M; Saenen, Johan; Hoeksema, Wiert F; Antiperovitch, Pavel; Tadros, Rafik; Christiansen, Morten K; Steinberg, Christian; Arnaud, Marine; Tian, Shanshan; Sun, Bo; Estillore, John Paul; Wang, Ruiwu; Khan, Habib R; Roston, Thomas M; Mazzanti, Andrea; Giudicessi, John R; Siontis, Konstantinos C; Alak, Aiman; Acosta, J Gabriel; Divakara Menon, Syamkumar M; Tan, Nigel S; van der Werf, Christian; Nazer, Babak; Vivekanantham, Hari; Pandya, Tanvi; Cunningham, Jennifer; Gula, Lorne J; Wong, Jorge A; Amit, Guy; Scheinman, Melvin M; Krahn, Andrew D; Ackerman, Michael J; Priori, Silvia G; Gollob, Michael H; Healey, Jeff S; Sacher, Frederic; Nof, Eyal; Glikson, Michael; Wilde, Arthur A M; Watkins, Hugh; Jensen, Henrik K; Postema, Pieter G; Belhassen, Bernard; Chen, S R Wayne; Roberts, Jason D.
Afiliação
  • Ni M; Libin Cardiovascular Institute, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
  • Dadon Z; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Ormerod JOM; Jesselson Integrated Heart Center, Eisenberg R&D Authority, Shaare Zedek Medical Center, and Hebrew University Faculty of Medicine, Jerusalem, Israel.
  • Saenen J; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, England.
  • Hoeksema WF; Oxford Heart Centre, John Radcliffe Hospital, Oxford, England.
  • Antiperovitch P; Department of Cardiology, Faculty of Medicine and Health Sciences, Antwerp University Hospital, Antwerp, Belgium.
  • Tadros R; Cardiovascular Research, Departments of Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Christiansen MK; Member of the European Reference Network for Rare, Low Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart).
  • Steinberg C; Department of Clinical Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Arnaud M; Heart Failure and Arrhythmias, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Tian S; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, Ontario, Canada.
  • Sun B; Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.
  • Estillore JP; Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.
  • Wang R; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Quebec, Canada.
  • Khan HR; Department of Cardiac Pacing and Electrophysiology, Hopital Cardiologique du Haut-Leveque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France.
  • Roston TM; Libin Cardiovascular Institute, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
  • Mazzanti A; Libin Cardiovascular Institute, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
  • Giudicessi JR; Libin Cardiovascular Institute, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
  • Siontis KC; Libin Cardiovascular Institute, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
  • Alak A; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, Ontario, Canada.
  • Acosta JG; Division of Cardiology and Centre for Cardiovascular Innovation, University of British Columbia, Vancouver, Canada.
  • Divakara Menon SM; Member of the European Reference Network for Rare, Low Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart).
  • Tan NS; Department of Molecular Cardiology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
  • van der Werf C; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Nazer B; Windland Smith Rice Genetic Heart Rhythm Clinic, Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Vivekanantham H; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Pandya T; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Cunningham J; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Gula LJ; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Wong JA; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Amit G; Member of the European Reference Network for Rare, Low Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart).
  • Scheinman MM; Department of Clinical Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Krahn AD; Heart Failure and Arrhythmias, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Ackerman MJ; Section of Cardiac Electrophysiology, Division of Cardiology, University of Washington Medical Center, Seattle.
  • Priori SG; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Gollob MH; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Healey JS; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Sacher F; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, Ontario, Canada.
  • Nof E; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Glikson M; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Wilde AAM; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of California, San Francisco.
  • Watkins H; Division of Cardiology and Centre for Cardiovascular Innovation, University of British Columbia, Vancouver, Canada.
  • Jensen HK; Windland Smith Rice Genetic Heart Rhythm Clinic, Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Postema PG; Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.
  • Belhassen B; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota.
  • Chen SRW; Department of Molecular Cardiology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
  • Roberts JD; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
JAMA ; 332(3): 204-213, 2024 07 16.
Article em En | MEDLINE | ID: mdl-38900490
ABSTRACT
Importance Sudden death and cardiac arrest frequently occur without explanation, even after a thorough clinical evaluation. Calcium release deficiency syndrome (CRDS), a life-threatening genetic arrhythmia syndrome, is undetectable with standard testing and leads to unexplained cardiac arrest.

Objective:

To explore the cardiac repolarization response on an electrocardiogram after brief tachycardia and a pause as a clinical diagnostic test for CRDS. Design, Setting, and

Participants:

An international, multicenter, case-control study including individual cases of CRDS, 3 patient control groups (individuals with suspected supraventricular tachycardia; survivors of unexplained cardiac arrest [UCA]; and individuals with genotype-positive catecholaminergic polymorphic ventricular tachycardia [CPVT]), and genetic mouse models (CRDS, wild type, and CPVT were used to define the cellular mechanism) conducted at 10 centers in 7 countries. Patient tracings were recorded between June 2005 and December 2023, and the analyses were performed from April 2023 to December 2023. Intervention Brief tachycardia and a subsequent pause (either spontaneous or mediated through cardiac pacing). Main Outcomes and

Measures:

Change in QT interval and change in T-wave amplitude (defined as the difference between their absolute values on the postpause sinus beat and the last beat prior to tachycardia).

Results:

Among 10 case patients with CRDS, 45 control patients with suspected supraventricular tachycardia, 10 control patients who experienced UCA, and 3 control patients with genotype-positive CPVT, the median change in T-wave amplitude on the postpause sinus beat (after brief ventricular tachycardia at ≥150 beats/min) was higher in patients with CRDS (P < .001). The smallest change in T-wave amplitude was 0.250 mV for a CRDS case patient compared with the largest change in T-wave amplitude of 0.160 mV for a control patient, indicating 100% discrimination. Although the median change in QT interval was longer in CRDS cases (P = .002), an overlap between the cases and controls was present. The genetic mouse models recapitulated the findings observed in humans and suggested the repolarization response was secondary to a pathologically large systolic release of calcium from the sarcoplasmic reticulum. Conclusions and Relevance There is a unique repolarization response on an electrocardiogram after provocation with brief tachycardia and a subsequent pause in CRDS cases and mouse models, which is absent from the controls. If these findings are confirmed in larger studies, this easy to perform maneuver may serve as an effective clinical diagnostic test for CRDS and become an important part of the evaluation of cardiac arrest.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eletrocardiografia Limite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eletrocardiografia Limite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá